ArticlebioRxiv : the preprint server for biology2025
Specification of frequency criteria for secondary findings genes to improve variant classification concordance.
Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Updated by
Authors and funding
5 authors.
Funding
Abstract
Purpose: The return of secondary findings (SF) is well-established in clinical testing and is increasingly employed in clinical research testing. Variant classification can be challenging due to the lack of monogenic disease entity (MDE, defined as a gene-phenotype pair) specific variant classification recommendations. A key criterion for variant classification is disease allele frequency thresholds (DAFTs), which are not established for all MDEs recommended for the return of SF. Methods: We calculated DAFTs for SF MDEs considering prevalence, gene contribution, and penetrance. ACMG criterion BS1 was set at the calculated DAFT value, with BA1 set at ten times the calculated DAFT. For genes associated with multiple SF MDEs without clear genotype-phenotype correlation, DAFT values were combined. GnomAD Grpmax filtering allele frequencies (FAF) for pathogenic/likely pathogenic classified variants were compared to calculated thresholds. Results: We determined BS1 and BA1 values for 58 SF MDEs (47 genes). No pathogenic/likely pathogenic variant Grpmax FAF was greater than the relevant MDE-specific BA1. Conclusion: Setting BA1 and BS1 thresholds should improve variant classification consistency and reduce misclassifications. For SF MDEs without current ClinGen Variant Curation Expert Panel (VCEP) specifications, these frequency specifications can be used until full criteria are available.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.